Once versus twice daily formoterol via Novolizer® for patients with moderate to severe COPD—A double-blind, randomised, controlled trial
| Autor: | Welte, T.1 welte.tobias@mh-hannover.de, Metzenauer, P.2, Hartmann, U.2 |
|---|---|
| Zdroj: | Pulmonary Pharmacology & Therapeutics. Feb2008, Vol. 21 Issue 1, p4-13. 10p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|
Full Text from ScienceDirect